Sign in Subscribe

Teladoc Stock Surges as Deutsche Bank Calls Shares "Compelling" and Sees Exit Upside

Deutsche Bank upgrades Teladoc Health to Buy from Hold with $11 price target, calling valuation compelling amid BetterHelp stabilization and potential exit upside.

Teladoc Stock Surges as Deutsche Bank Calls Shares "Compelling" and Sees Exit Upside
Credit: Michael Nagle/Bloomberg/Getty Images
Already have an account? Sign in.